Table 3.
Univariable Cox regression analysis after the LASSO regression analysis, without tumor invasion locations.
Variables | N | HR | 95% CI | p |
---|---|---|---|---|
BMI | 0.214 | |||
<25 | 161 | |||
≥25 | 138 | 0.723 | [0.434,1.206] | |
T category | 0.002 | |||
Ta | 181 | 1 (reference) | ||
T1 | 118 | 2.206 | [1.332,3.652] | |
Prior recurrence status | <0.001 | |||
Primary | 264 | 1 (reference) | ||
Recurrent | 35 | 3.369 | [1.941,5.847] | |
Tumor number | 0.016 | |||
Single | 146 | 1 (reference) | ||
Multiple | 153 | 1.911 | [1.127,3.241] | |
Gross hematuria | 0.171 | |||
No | 60 | 1 (reference) | ||
Yes | 239 | 1.682 | [0.800,3.538] | |
Times of IVI | <0.001 | |||
0-1 | 36 | 1 (reference) | ||
2-12 | 56 | 0.534 | [0.296,0.961] | 0.036 |
>12 | 207 | 0.081 | [0.043,0.152] | <0.001 |
SII | 0.003 | |||
<525.26 | 215 | 1(reference) | ||
≥525.26 | 84 | 2.17 | [1.308,3.599] |
HR, hazard ratio; CI, confidence interval; BMI, body mass index, weight/height2; IVI,intravesical instillation; PLR, platelet-lymphocyte ratio; SII, systemic immune-inflammation index,platelet* neutrophil/lymphocyte; De Ritis ratio, aspartate transaminase/alanine transaminase. Bolded p-values indicate statistically significant correlations (p < 0.05).